Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Uyttenhove, Catherine, Pilotte, Luc, Théate, Ivan, Stroobant, Vincent, Colau, Didier, Parmentier, Nicolas, Boon, Thierry, Van den Eynde, Benoît J·2003·Nature Medicine

DOI 10.1038/nm934

Cited by (1,003)

Items 301–400 of 1,003

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
Christiane A. Opitz, Ulrike M. Litzenburger, Uta Opitz, Felix Sahm, Katharina Ochs, Christian Lutz, Wolfgang Wick, Michael Platten · 2011 · PLoS ONE
Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang‐Kyou Lee · 2020 · Immune Network
Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites
Helena Harlin, Todd V. Kuna, Amy Peterson, Yuru Meng, Thomas F. Gajewski · 2006 · Cancer Immunology Immunotherapy
Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease
Simon P. Jones, Nunzio F. Franco, Bianca Varney, Gayathri Sundaram, David Alexander Brown, Josien de Bie, Chai K. Lim, Gilles J. Guillemin, Bruce James Brew · 2015 · PLoS ONE
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, Andrew Maltez, Fidelle, Marine, Routy, Bertrand, Kroemer, Guido, Wargo, Jennifer A., Segata, Nicola, Zitvogel, Laurence · 2023 · Nature Reviews Clinical Oncology
Why tumours eat tryptophan
George C. Prendergast · 2011 · Nature
Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
Sundary Sormendi, Ben Wielockx · 2018 · Frontiers in Immunology
Cancer Immunotherapy: Accomplishments to Date and Future Promise
Karim Y. Helmy, Shyam Ajay Patel, George R. Nahas, Pranela Rameshwar · 2013 · Therapeutic Delivery
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
Caroline Jochéms, Massimo Claudio Fantini, Romaine Ingrid Fernando, Anna R. Kwilas, Renee Nicole Donahue, Lauren Marissa Lepone, Italia Grenga, Young‐Seung Kim, Martin W. Brechbiel, James L. Gulley et al. · 2016 · Oncotarget
Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma
Jinkai Liu, Wei Geng, Hanyong Sun, Changan Liu, Fan Huang, Jie Cao, Lei Xia, Hongchuan Zhao, Jianning Zhai, Qing Li et al. · 2021 · Gut
Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
Thomas Frank Gajewski, Mercedes Beatriz Fuertes, Robbert M. Spaapen, Yan Zheng, Justin Paul Kline · 2010 · Current Opinion in Immunology
Understanding the role of the kynurenine pathway in human breast cancer immunobiology
Benjamin Heng, Chai K. Lim, David B. Lovejoy, Alban Bessede, Laurence Gluch, Gilles J. Guillemin · 2015 · Oncotarget
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
Amy B. Dounay, Jamison B. Tuttle, Patrick R. Verhoest · 2015 · Journal of Medicinal Chemistry
Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
Soumaya Kouidhi, Amel Benammar Elgaaïed, Salem Chouaı̈b · 2017 · Frontiers in Immunology
Multiscale technologies for treatment of ischemic cardiomyopathy
Morteza Mahmoudi, Mikyung Yu, Vahid Serpooshan, Joseph C. Wu, Róbert Langer, Richard Theodore Lee, Jeffrey M. Karp, Omid Cameron Farokhzad · 2017 · Nature Nanotechnology
Mechanisms of malignant glioma immune resistance and sources of immunosuppression.
German G. Gomez, Carol A. Kruse · 2006 · PubMed
Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase
Xuexiang Han, Keman Cheng, Ying Xu, Yazhou Wang, Huan Min, Yinlong Zhang, Xiao Zhao, Ruifang Zhao, Gregory Jon Anderson, Lei Ren et al. · 2020 · Journal of the American Chemical Society
Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor
Abduelhakem Ben Addi, Anne Lefort, Xiaoyang Hua, Frédérick Libert, Didier Communi, Catherine A. Ledent, Pascale Macours, Stephen L. Tilley, Jean‐Marie Boeynaems, Bernard Robaye · 2008 · European Journal of Immunology
The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct
Christian Brandl, Cornelia Haas, Sandrine d’Argouges, Tanja Fisch, Peter Kufer, Klaus Brischwein, Nadja S. Prang, Ralf Christian Bargou, JoAnn Suzich, Patrick A. Baeuerle et al. · 2007 · Cancer Immunology Immunotherapy
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO
Giada Mondanelli, Stefano Ugel, Ursula Grohmann, Vincenzo Bronte · 2017 · Current Opinion in Pharmacology
Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
William R. Strohl, Michael F. Naso · 2019 · Antibodies
Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle
Qianqian Li, Zhaoqing Shi, Fan Zhang, Weiwei Zeng, Dunwan Zhu, Lin Mei · 2021 · Acta Pharmaceutica Sinica B
Blocking IDO activity to enhance anti-tumor immunity
David H. Munn · 2012 · Frontiers in Bioscience-Elite
The significant role of amino acid metabolic reprogramming in cancer
Xiaohong Liu, Bo Ren, Jie Ren, Minzhi Gu, Lei You, Yu-pei Zhao · 2024 · Cell Communication and Signaling
The roles of arginases and arginine in immunity
Stefania Canè, Roger Geiger, Vincenzo Bronte · 2024 · Nature reviews. Immunology
Involvement of quinolinic acid in aids dementia complex
Gilles J. Guillemin, Stephen John Kerr, Bruce James Brew · 2005 · Neurotoxicity Research
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
Alka Bhatia, Yashwant Kumar · 2013 · Expert Review of Clinical Immunology
Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
Cynthia M. Fehres, Wendy W. J. Unger, Juan Jesús García-Vallejo, Yvette van Kooyk · 2014 · Frontiers in Immunology
Role of immune cells in pancreatic cancer from bench to clinical application
Jae Hyuck Chang, Yongjian Jiang, Venu Gopal Pillarisetty · 2016 · Medicine
Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
Juliane Günther, Jan Däbritz, Elisa Wirthgen · 2019 · Frontiers in Immunology
iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma
Jing Kuang, Wen Long Song, Jun Yin, Xuan Zeng, Song Hee Han, Yipeng Zhao, Jun Tao, Chuan‐Jun Liu, Xiaohua He, Xian‐Zheng Zhang · 2018 · Advanced Functional Materials
Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
Andreas Herrmann, Marcin Kortylewski, Maciej Kujawski, Chunyan Zhang, Karen L. Reckamp, Brian Armstrong, Lin Qi Wang, Claudia M. Kowolik, Jiehui Deng, Robert A. Figlin et al. · 2010 · Cancer Research
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
Kerr, William G, Chisholm, John D · 2019 · The Journal of Immunology
Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine: Role of IDO
Gargi Dan Basu, Teresa L. Tinder, Judy Martina Bradley, Tony Tu, Christine L. Hattrup, Barbara A. Pockaj, Pinku Mukherjee · 2006 · The Journal of Immunology
Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense
Luan, Harding H., Medzhitov, Ruslan · 2016 · Cell Metabolism
Glutamine Metabolism in Cancer
Ting Li, Christopher Copeland, Anne Le · 2021 · Advances in experimental medicine and biology
Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
Florent Peyraud, Jean‐Philippe Guégan, D. Bodet, Sophie Cousin, Alban Bessede, Antoîne Italiano · 2022 · Frontiers in Immunology
Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship
Ngozi R. Monu, Alan B. Frey · 2012 · Immunological Investigations
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
Lijie Zhai, April Bell, Erik Ladomersky, Kristen L. Lauing, Lakshmi Bollu, Brenda Nguyen, Matthew Genet, Miri Kim, Peiwen Chen, Xinlei Mi et al. · 2021 · Clinical Cancer Research
Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease
Antonio Macchiarulo, Emidio Camaioni, Roberto Nuti, Roberto Pellicciari · 2008 · Amino Acids
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation
Hui Xu, Timothy B. Oriss, Mingjian Fei, Adam C. Henry, Barbro N. Melgert, Li Chen, Andrew L. Mellor, David H. Munn, Charles G. Irvin, Prabir Ray et al. · 2008 · Proceedings of the National Academy of Sciences
Targeting Tregs in Malignant Brain Cancer: Overcoming IDO
Derek A. Wainwright, Mahua Dey, Alan Lee Chang, Maciej S. Lesniak · 2013 · Frontiers in Immunology
Indoleamine 2,3-Dioxygenase Tissue Distribution and Cellular Localization in Mice: Implications for Its Biological Functions
Xiangchen Dai, Bao Ting Zhu · 2009 · Journal of Histochemistry & Cytochemistry
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Yun Liu, Jianfeng Guo, Leaf Huang · 2020 · Theranostics
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
Fang Wei, Dan Wang, Junyuan Wei, Niwen Tang, Le Min Tang, Fang Xiong, Can Jie Guo, Ming Zhou, Xiaoling Li, Guiyuan Li et al. · 2020 · Cellular and Molecular Life Sciences
The Role of Vascular Cell Adhesion Molecule-1 in Tumor Immune Evasion
T.‐C. Wu · 2007 · Cancer Research
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
Anke Vanderstraeten, C. Luyten, Godelieve Verbist, Sandra Tuyaerts, Frédéric C. Amant · 2014 · Cancer Immunology Immunotherapy
Mechanisms of resistance to immune checkpoint inhibitors
Joji Nagasaki, Takamasa Ishino, Yosuke Togashi · 2022 · Cancer Science
Systemic tryptophan homeostasis
Simon Klaessens, V. Stroobant, E. de Plaen, B. Van den Eynde · 2022 · Frontiers in Molecular Biosciences
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity
Carole Guillonneau, Justine D. Mintern, François‐Xavier Hubert, Aeron C. Hurt, Gurdyal Singh Besra, Steven Anthony Porcelli, Ian Barr, Peter C. Doherty, Dale Ian Godfrey, Stephen J. Turner · 2009 · Proceedings of the National Academy of Sciences
TGF-β and kynurenines as the key to infectious tolerance
Maria Laura Belladonna, Ciriana Orabona, Ursula Grohmann, Paolo Puccetti · 2009 · Trends in Molecular Medicine
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
David Samuel Alberts, Christian Marth, Ronald David Alvarez, Gary A. Johnson, Mariusz Bidziński, David R. Kardatzke, Williamson Z. Bradford, Jeffery S. Loutit, David H. Kirn, Mary C. Clouser et al. · 2008 · Gynecologic Oncology
Exiguamine A, an Indoleamine-2,3-dioxygenase (IDO) Inhibitor Isolated from the Marine Sponge Neopetrosia exigua
Harry C. Brastianos, Eduardo Vottero, Brian O. Patrick, Rob W. M. van Soest, Teatulohi K. Matainaho, A. Grant Mauk, Raymond J. Andersen · 2006 · Journal of the American Chemical Society
Novel prospects of statins as therapeutic agents in cancer
Simona Pisanti, Paola Picardi, Elena Ciaglia, Alba D’Alessandro, Maurizio Bifulco · 2014 · Pharmacological Research
Kidney Tumor Biomarkers Revealed by Simultaneous Multiple Matrix Metabolomics Analysis
Sheila N. Ganti, Sandra L. Taylor, Omran Abu Aboud, Joy C. Yang, Christopher P. Evans, Michael V. Osier, Danny C. Alexander, Kyoungmi Kim, Robert H. Weiss · 2012 · Cancer Research
Epigenetic polypharmacology: A new frontier for epi‐drug discovery
Daniela Tomaselli, Alessia Lucidi, Dante Rotili, Antonello Mai · 2019 · Medicinal Research Reviews
Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
Agnieszka Katarzyna Witkiewicz, Christina L. Costantino, Richard A. Metz, Alexander J. Muller, George C. Prendergast, Charles J. Yeo, Jonathan Robert Brody · 2009 · Journal of the American College of Surgeons
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators
Rikke Bæk Sørensen, Sine Reker Hadrup, Inge Marie Svane, Mads Christian Hjortsø, Per thor Straten, Mads Hald Andersen · 2010 · Blood
Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
Trine Zeeberg Iversen, Lotte Engell-Noerregaard, Eva Ellebæk, Rikke Sick Andersen, Stine Kiær Larsen, Jon Bjoern, Claus Zeyher, Cécile Gouttefangeas, Birthe Moerk Thomsen, Bente Holm et al. · 2013 · Clinical Cancer Research
Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer
Eric E. Fox, Thomas Oliver, Melissa M. Rowe, Sunil Thomas, Yousef Zakharia, Paul B. Gilman, Alexander J. Muller, George C. Prendergast · 2018 · Frontiers in Oncology
Kynurenine emerges from the shadows – Current knowledge on its fate and function
Marta Marszałek‐Grabska, Katarzyna Walczak, Kinga Gaweł, Katarzyna Wicha-Komsta, Sylwia Wnorowska, Artur Wnorowski, Waldemar Andrzej Turski · 2021 · Pharmacology & Therapeutics
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, Abubakar Nazir, Gafar Babatunde Bamigbade, Narjiss Aji, Poulami Roy, Hajar kachani, Neil K. Garg, Lukman Lawal et al. · 2024 · European journal of medical research
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
Botticelli, Andrea, Cerbelli, Bruna, Lionetto, Luana, Zizzari, Ilaria, Salati, Massimiliano, Pisano, Annalinda, Federica, Mazzuca, Simmaco, Maurizio, Nuti, Marianna, Marchetti, Paolo · 2018 · Journal of Translational Medicine
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
Ho, Ping-Chih, Liu, Pu-Ste · 2016 · Journal for ImmunoTherapy of Cancer
Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
Marc Hilmi, Laurent Bartholin, Cindy Neuzillet · 2018 · World Journal of Gastroenterology
CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model
Kutlu G. Elpek, Chantale Lacelle, Narendra Prasad Singh, Esma S. Yolcu, Haval Shirwan · 2007 · The Journal of Immunology
Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells
Alessandro Delli Poggi, Alessandra Musso, Irene Dapino, Maria Raffaella Zocchi · 2014 · Immunology Letters
Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy
Senthil K. Karunakaran, Nagavedi Siddaramappa Umapathy, Muthusamy Thangaraju, Takahiro Hatanaka, Shiro Itagaki, David H. Munn, Puttur Devi Prasad, Vadivel Ganapathy · 2008 · Biochemical Journal
Cancer Immunotherapy: Selected Targets and Small‐Molecule Modulators
Hilmar Weinmann · 2016 · ChemMedChem
A Cisplatin‐Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy
Na Wang, Zhigang Wang, Zoufeng Xu, Xianfeng Chen, Guangyu Zhu · 2018 · Angewandte Chemie International Edition
Nanosensor Detection of an Immunoregulatory Tryptophan Influx/Kynurenine Efflux Cycle
Thijs Kaper, Loren L. Looger, Hitomi Takanaga, Michael Platten, Lawrence Steinman, Wolf Bernd Frommer · 2007 · PLoS Biology
Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
Lauren M.F. Merlo, James B. DuHadaway, James D. Montgomery, Weidan Peng, Peter J. Murray, George C. Prendergast, Andrew J. Caton, Alexander J. Muller, Laura Mandik‐Nayak · 2020 · Frontiers in Immunology
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, Maomao Li, Jing Zuo, Bohao Zheng, Wei Wang, Ping Wang, Shengtao Zhou · 2022 · Molecular Cancer
IDO: A double-edged sword for TH1/TH2 regulation
Hui Xu, Guang‐Xian Zhang, Bogoljub Ćirić, Abdolmohamad M. Rostami · 2008 · Immunology Letters
Opportunities for Small Molecules in Cancer Immunotherapy
van der Zanden, Sabina Y., Luimstra, Jolien J., Neefjes, Jacques, Borst, Jannie, Ovaa, Huib · 2020 · Trends in Immunology
Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
Paris Kosti, John F. Maher, James N. Arnold · 2018 · Frontiers in Immunology
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma
Zachary J. Brown, Su Jong Yu, Bernd Heinrich, Chi Ma, Qiong Fu, Milan Sandhu, David Agdashian, Qianfei Zhang, Firouzeh Korangy, Tim F. Greten · 2018 · Cancer Immunology Immunotherapy
Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer
Baosheng Chen, David M. Alvarado, Micah S. Iticovici, Nathan S. Kau, Haeseong Park, Parag Jitendra Parikh, Dinesh Kumar Thotala, Matthew A. Ciorba · 2020 · Cancer Immunology Research
Vascular tumors of infancy and childhood: beyond capillary hemangioma
Paula E. North, Milton Waner, Lisa M. Buckmiller, Charles A. James, Martín C. Mihm · 2006 · Cardiovascular Pathology
Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis
Yuzo Suzuki, Takafumi Suda, Kazuhiro Asada, Seiichi Miwa, Masako Suzuki, Michio Fujie, Kazuki Furuhashi, Yutaro Nakamura, Naoki Inui, Toshihiro Shirai et al. · 2012 · Clinical and Vaccine Immunology
Recent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, Gwendal, Lam, Paula Y. · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages
Amélie Carbonnelle-Puscian, Christiane Copie‐Bergman, Maryse Baia, Nadine Martin‐Garcia, Yves Allory, Corinne Haïoun, Anne Cremades, Issam Abd‐Alsamad, Jean‐Pierre Farcet, Philippe Gaulard et al. · 2009 · Leukemia
Immune evasion in acute myeloid leukemia: current concepts and future directions
Ryan M. Teague, Justin Paul Kline · 2013 · Journal for ImmunoTherapy of Cancer
Indoleamine 2,3 dioxygenase in intestinal disease
Matthew A. Ciorba · 2012 · Current Opinion in Gastroenterology
Marrying Immunotherapy with Chemotherapy: Why Say IDO?
Alexander J. Muller, George C. Prendergast · 2005 · Cancer Research
Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer
Wenhui Li, Ming Lu Xu, Yu Li, Ziwei Huang, Jun Zhou, Qiuyang Zhao, Kehao Le, Fang Dong, Cheng Wan, Pengfei Yi · 2020 · Journal of Translational Medicine
Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment
Chenfei Zhou, Yanmei Zhang, Rui-Ming Yan, Lei Huang, Andrew L. Mellor, Yang Yang, Xiaojing Chen, Wen-Fei Wei, Xiang‐Guang Wu, Lan Yu et al. · 2020 · Cell Death and Differentiation
Tryptophan potentiates CD8 + T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation
Rui Qin, Chen Zhao, Chenji Wang, Wei Xu, Jian‐Yuan Zhao, Yan Lin, Yiyuan Yuan, Pengcheng Lin, Yao Li, Shimin Zhao et al. · 2021 · Journal for ImmunoTherapy of Cancer
The Role of Placental Tryptophan Catabolism
Peter Sedlmayr, Astrid Blaschitz, Roland Stocker · 2014 · Frontiers in Immunology
Blocking IDO activity to enhance anti-tumor immunity
David, H. Munn · 2011 · Frontiers in Bioscience-Elite
The Immune System — is it Relevant to Cancer Development, Progression and Treatment?
Robin J D Prestwich, Fiona Errington‐Mais, Paul Hatfield, Alison E. Merrick, Elizabeth J. Ilett, Peter John Selby, Alan A. Melcher · 2007 · Clinical Oncology
Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors
Alexander J. Muller, William P. Malachowski, George C. Prendergast · 2005 · Expert Opinion on Therapeutic Targets
Opposing Biological Functions of Tryptophan Catabolizing Enzymes During Intracellular Infection
Senad Divanovic, Nancy M. Sawtell, Aurélien Trompette, Jamie I. Warning, Alexandra Dias, Andrea May Cooper, George S. Yap, Moshe Arditi, Kenichi Shimada, James B. DuHadaway et al. · 2011 · The Journal of Infectious Diseases
A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth
Qian Li, Di Zhang, Jing Zhang, Yue Jiang, Aixin Song, Zhonghao Li, Yuxia Luan · 2019 · Nano Letters
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michaël Cerezo, Stéphane Rocchi · 2020 · Cell Death and Disease
Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T Lymphocytes
Yozo Nakazawa, Leslie E. Huye, Gianpietro Dotti, Aaron Edward Foster, Juan F. Vera, Pallavi R. Manuri, Carl H. June, Cliona M. Rooney, Matthew H. Wilson · 2009 · Journal of Immunotherapy
Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism
Heather M. Grifka‐Walk, Brittany R. Jenkins, Douglas J. Kominsky · 2021 · Frontiers in Immunology
Tumor metabolism as modulator of immune response and tumor progression
Eva Gottfried, Marina P Kreutz, Andréas Mackensen · 2012 · Seminars in Cancer Biology
Tumor immune escape mediated by indoleamine 2,3-dioxygenase
Μαρία Ζαμανάκου, Anastasios E. Germenis, Vaios Karanikas · 2007 · Immunology Letters
Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation
Ligi Paul, Per Magne Ueland, Jacob Selhub · 2013 · Nutrition Reviews